Cargando…

Reply: Iron chelation may harm patients with COVID-19

Detalles Bibliográficos
Autor principal:	Abobaker, Anis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459945/ https://www.ncbi.nlm.nih.gov/pubmed/32870381 http://dx.doi.org/10.1007/s00228-020-02988-9

Ejemplares similares

Iron chelation may harm patients with COVID-19
por: Garrick, Michael D., et al.
Publicado: (2020)

Can iron chelation as an adjunct treatment of COVID-19 improve the clinical outcome?
por: Abobaker, Anis
Publicado: (2020)

Correction to: Iron chelation may harm patients with COVID-19
por: Garrick, Michael D., et al.
Publicado: (2021)

The effect of COVID-19 on parathyroid glands
por: Abobaker, Anis, et al.
Publicado: (2021)

COVID‐19 infection as a possible cause of complete heart block: What do we know so far?
por: Abobaker, Anis
Publicado: (2022)

Letter to the Editor From Abobaker and Darrat: “Circulating Levels of Calcitonin Gene-Related Peptide Are Lower in COVID-19 Patients”
por: Abobaker, Anis, et al.
Publicado: (2021)

The Eye: A Possible New Route of Infection in COVID-19
por: Abobaker, Anis, et al.
Publicado: (2020)

Does COVID-19 affect male fertility?
por: Abobaker, Anis, et al.
Publicado: (2020)

Impact of the COVID-19 Pandemic on Postoperative Follow-up After a Total Hip and Knee Joints Replacement
por: Abobaker, Anis, et al.
Publicado: (2020)

COVID-19 in Libya: Fewer Cases So Far. Any Speculations?
por: Gasibat, Qais, et al.
Publicado: (2020)

Colchicine may not be effective in COVID-19 infection; it may even be harmful?
por: Cumhur Cure, Medine, et al.
Publicado: (2020)

Iron chelation in treatment of superficial siderosis
por: Derle, Eda
Publicado: (2018)

Comment on “Colchicine may not be effective in COVID-19 infection; it may even be harmful?”
por: Kobak, Senol
Publicado: (2020)

Reply to “Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19”
por: Khan, Md. Saiful Islam, et al.
Publicado: (2021)

Should every Patient with MDS get Iron Chelation – Probably Yes
por: Ghosh, Kanjaksha, et al.
Publicado: (2017)

V1 and V2 pericordial leads misplacement and its negative impact on ECG interpretation and clinical care
por: Abobaker, Anis, et al.
Publicado: (2021)

Efficacy and safety of combined oral iron chelation therapy with deferasirox and deferiprone in a patient with beta-thalassemia major and persistent iron overload
por: Alavi, Samin, et al.
Publicado: (2014)

Normal pregnancy in a patient with β-thalassaemia major receiving iron chelation therapy with deferasirox (Exjade®)
por: Vini, Dimitra, et al.
Publicado: (2011)

Iron deficiency anemia and its treatment - reply
por: Cançado, Rodolfo Delfini
Publicado: (2011)

Impact of labile plasma iron and iron chelation on the viability of cultured mononuclear cells from patients undergoing autologous hematopoietic stem cell transplantation
por: Naoum, Flávio Augusto, et al.
Publicado: (2017)

Reply to “Novaferon, treatment in COVID-19 patients”
por: Zheng, Fang, et al.
Publicado: (2021)

In Reply: Hormones and COVID-19
por: Park, Myung S., et al.
Publicado: (2023)

Sophism in the Management of Acute Aluminum Phosphide Poisoning may Cause Patient Harm
por: Farahani, Maryam Vasheghani, et al.
Publicado: (2017)

Reply to “Consensus document on tracheotomy in patients with COVID-19”()
por: Martín Delgado, M.C., et al.
Publicado: (2021)

Reply to: Trajectories of vital signs in patients with Covid-19
por: Redfern, Oliver C., et al.
Publicado: (2021)

Reply to Consensus document on tracheotomy in patients with COVID 19()
por: Pérez Acosta, G., et al.
Publicado: (2021)

Reply to “The outbreak of COVID-19: An overview”
por: Wu, Yi-Chi, et al.
Publicado: (2020)

Reply: CPET for Long COVID-19
por: Mancini, Donna M., et al.
Publicado: (2022)

Reply to the syndemic of “COVID-19 and tuberculosis”
por: Patil, Rajashri A., et al.
Publicado: (2023)

Intravenous ferric carboxymaltose for the treatment of iron deficiency anaemia – reply
por: Cancado, Rodolfo Delfini, et al.
Publicado: (2020)

Non-recommended medical interventions and their possible harm in patients with COVID-19
por: Pecho-Silva, Samuel, et al.
Publicado: (2021)

Serum iron may not be linked with migraine
por: Gupta, Ravi, et al.
Publicado: (2013)

Reply to: Prognostic implications of vitamin D in patients with COVID-19
por: Hastie, Claire E., et al.
Publicado: (2020)

Reply to the Letter to the Editor “Pathogenesis of pneumoperitoneum in COVID-19 patients”()
por: Gemio del Rey, Ignacio Antonio, et al.
Publicado: (2021)

Antenatal corticosteroids and COVID-19: balancing benefits and harms
por: Liauw, Jessica, et al.
Publicado: (2020)

Plasma hemoglobin in COVID-19: authors’ reply
por: Lancman, Guido, et al.
Publicado: (2020)

In reply—The “Perfect Cytokine Storm” of COVID-19
por: Vijayvargiya, Prakhar, et al.
Publicado: (2020)

Reply To: Response to COVID-19 by the surgical community
por: Chapman, Robert
Publicado: (2020)

Type and dose of heparin in Covid‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)

Reply to Comment on “Osteoporosis in the Age of COVID-19”
por: Girgis, C. M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5irhavd7dmos94nhhusbbnesg1